ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,184, issued on Sept. 8, was assigned to Alivus Life Sciences Ltd. (Solapur, India). "Process for the preparation of Olaparib, and crystalli... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,185, issued on Sept. 8, was assigned to INSTITUTE FOR BASIC SCIENCE (Daejeon, South Korea) and KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHN... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,186, issued on Sept. 8, was assigned to Liangjiang Medicine Co. Ltd. (Chongqing, China). "Prodrugs for sustained releasing therapeutic agen... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,187, issued on Sept. 8, was assigned to ARCHER-DANIELS-MIDLAND COMPANY (Decatur, Ill.). "Oxidative pretreatment of carbohydrate dehydration... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,188, issued on Sept. 8, was assigned to DSM IP ASSETS B.V. (Maastricht, Netherlands). "Ring closure of benzoquinones containing an unsatura... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,189, issued on Sept. 8, was assigned to NXERA PHARMA UK Ltd. (Cambridgeshire, Great Britain). "GPR52 modulator compounds" was invented by S... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,190, issued on Sept. 8, was assigned to Baylor College of Medicine (Houston). "Coronavirus main protease inhibitors and methods using same"... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,191, issued on Sept. 8, was assigned to Eisai R&D Management Co. Ltd. (Tokyo). "Production method for synthetic intermediate of monocyclic ... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,192, issued on Sept. 8, was assigned to PHARMABLOCK SCIENCES (NANJING) INC. (Nanjing, China). "CDK9 inhibitor and use thereof" was invented... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,193, issued on Sept. 8, was assigned to C4 Therapeutics Inc. (Watertown, Mass.). "Tricyclic ligands for degradation of IKZF2 or IKZF4" was ... Read More